|

SOC Chemotherapy Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Kathy Miller1

Indications

  • Estrogen-receptor-low Breast Cancer1
  • Metastatic Breast Cancer1
  • Triple Negative Breast Cancer1
  • Breast Cancer1
  • Cancer1

Atlanta, Georgia1 trial

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

Emory University

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.